Eine Auswahl an Publikationen von Dr. rer. nat. Gerald Willimsky

Schmidt K, Zilio S, Schmollinger JC, Bronte V, Blankenstein T, Willimsky G
Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
Blood 2013; 121(10):1740-8.
Willimsky G, Protzer U, Knolle P, Heikenwalder M
Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key.
Oncotarget 2013; 4(8):1117-8.
Listopad JJ, Kammertoens T, Anders K, Silkenstedt B, Willimsky G, Schmidt K, Kuehl AA, Loddenkemper C, Blankenstein T
Fas expression by tumor stroma is required for cancer eradication.
Proc Natl Acad Sci U S A 2013; 5110(6):2276-81.
Willimsky G, Schmidt K, Loddenkemper C, Gellermann J, Blankenstein T
Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.
J Clin Invest 2013; 123(3):1032-43.
Czéh M, Loddenkemper C, Shalapour S, Schön C, Robine S, Goldscheid E, Stein H, Schüler T, Willimsky G, Blankenstein T
The immune response to sporadic colorectal cancer in a novel mouse model.
Oncogene 2010; 29(50):6591-602.
Buschow C, Charo J, Anders K, Loddenkemper C, Jukica A, Alsamah W, Perez C, Willimsky G, Blankenstein T
In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance.
J Immunol 2010; 184(6):2930-8.
Willimsky G, Czéh M, Loddenkemper C, Gellermann J, Schmidt K, Wust P, Stein H, Blankenstein T
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.
J Exp Med 2008; 205(7):1687-700.
Li L, Willimsky G, Seitz S, Xu Y, Li Y, Schwarz LE, Schlag PM, Blankenstein T
SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium.
Int J Cancer 2008; 123(7):1516-25.
Willimsky G, Blankenstein T
The adaptive immune response to sporadic cancer.
Immunol Rev 2007; 220:102-12.
Willimsky G, Blankenstein T
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.
Nature 2005; 437(7055):141-6.


Bitte wenden Sie sich an Frau
Birgit Röders
t: +49 30 8445 2820